Additionally, GAD-65 is a major autoantigen in T1DM, and autoantibodies to GAD-65 are detected in 60–70% of individuals with newly diagnosed T1DM, suggesting that the destruction of beta cells may be mediated by the immune response against GAD-65 (17). This evidence concerns the gene GAD2 and type 1 diabetes mellitus.